Skip to main content

ORIGINAL RESEARCH article

Front. Cell Dev. Biol., 24 October 2024
Sec. Cellular Biochemistry
This article is part of the Research Topic Advances on Molecular Mechanisms Regulating Reproduction - From Gametogenesis to Fertilization View all 3 articles

Tle6 deficiency in male mice led to abnormal sperm morphology and reduced sperm motility

  • 1Research Support Center, Medical Research Institute, Kanazawa Medical University, Uchinada, Japan
  • 2Faculty of Life and Environmental Sciences, University of Yamanashi, Kofu, Japan

Infertility affects over 15% of the global population, and genetic mutations are a substantial cause of infertility. Recent studies have focused on the subcortical maternal complex and its role in early embryonic development. TLE6, a core protein in the subcortical maternal complex, is crucial for female fertility; however, its role in male germ cells remains poorly understood. In this study, we generated a novel Tle6 knockout mouse model using CRISPR-Cas9 to examine the impact of Tle6 mutations on male fertility. Tle6 knockout males exhibited a reduced total sperm count compared to wild-type mice, with a marked decrease in highly motile sperm. Histological observation of Tle6+/− mouse testes showed no apparent structural changes, though impaired sperm maturation was observed. Immunofluorescence staining showed that TLE6 localizes to the midpiece of sperm. It was also confirmed that the expression of Tle6 is reduced in Tle6+/− male mice. In addition, Tle6+/− mice exhibited a significant increase in serum testosterone levels compared to wild-type mice. Changes in the expression of genes related to sperm function were also observed in the testes of Tle6 knockout mice. These findings suggest that TLE6 is involved in sperm production and function, and that mutations in TLE6 may impair the production of functional sperm in humans, potentially leading to infertility.

1 Introduction

Currently, it is estimated that infertility impacts more than 15% of the global population, thereby representing a considerable global challenge (WHO, 2023; Vander Borght and Wyns, 2018). To date, numerous studies on infertility have revealed that infertility can be partly attributed to genetic mutations (Jiao et al., 2021). However, the mechanisms through which individual genetic variants can cause infertility are yet to be comprehensively elucidated. Although recent studies have reported early embryonic infertility due to impaired oocyte maturation, fertilization, and early embryo development (Jiao et al., 2021), several of these mechanisms remain unknown.

Among the cases of early embryonic infertility, infertility resulting from mutations in subcortical maternal complex (SCMC)-related genes has recently garnered considerable attention (Bebbere et al., 2014). SCMC reportedly plays a role in embryo development and cleavage (Yu et al., 2014). SCMC is essential for maintaining the unique structure of cytoplasmic lattices (CPL) within the oocyte cytoplasm, which is crucial for embryogenesis (Jentoft et al., 2023). CPLs accumulate proteins necessary for embryogenesis, such as tubulin, as well as proteins that regulate post-fertilization reprogramming, and temporarily inhibit the access of these accumulated proteins to the nucleus (Jentoft et al., 2023), thereby regulating proper embryonic development. Furthermore, proteins involved in genomic imprinting and embryonic genome activation accumulate within CPLs (Giaccari et al., 2024), underscoring the importance of SCMC-related genes in embryo development and genomic imprinting.

SCMC is composed of multiple protein groups, including the transducin-like enhancer of split 6 (TLE6), PADI6, and OOEP (Chi et al., 2024), and its structure is widely conserved among mammals (Bebbere et al., 2014; Bebbere et al., 2021). TLE6 is the most crucial SCMC member. In the absence of TLE6, the structural integrity of SCMC and CPL is compromised (Chi et al., 2024). Consequently, in TLE6-deficient mice, cell division gradually fails after the two-cell stage, resulting in embryo fragmentation and complete embryonic lethality at the morula stage (Yu et al., 2014). In humans, pathogenic mutations in TLE6 have been reported to cause early embryonic lethality, as demonstrated by investigations conducted in multiple countries (Alazami et al., 2015; Lin et al., 2020; Akbari et al., 2022). This accumulated evidence strongly suggests that TLE6 is an essential protein in female germ cells.

Although the function of TLE6 in female germ cells and its role in infertility have been reported, little is known regarding the importance of TLE6 in male germ cells. Feng et al. reported the cell cycle and proliferation rate following the knockout (KO) of the Tle6 gene in mouse spermatogonia using the CRISPR-Cas9 system. The authors found that the loss of TLE6 affected spermatogonia cell cycle progression, causing a slight delay in the cell growth rate (Feng et al., 2020). However, this study was limited to investigating the effects of Tle6 KO on mouse spermatogonia, and further research is required to explore its effects on other cell types in vivo. In addition, human case reports have focused only on females within families, and reproductive function has only been assessed in males with Tle6 mutations (Akbari et al., 2022). Investigating whether male carriers of Tle6 mutations can transmit these mutations to the next generation is important.

In this study, we examined the pathological effects of knocking down Tle6, which is known to affect female germ cells only, in male mice to better understand the effects of Tle6 mutations and deletions on reproduction. Our results revealed that Tle6 KO mice have a low contribution rate to germ cells, making it difficult to pass these mutations and deletions to the next generation. Based on findings, males with TLE6 mutations are less likely to pass these mutations to their offspring.

2 Materials and equipment

2.1 Animals

C57BL/6N male mice (8 weeks old) and female mice (3 weeks old), as well as ICR female mice (8 weeks old) used for embryo transfer, were purchased from Japan SLC, Inc. (Hamamatsu, Japan). Vasectomized male ICR mice were bred and maintained at our facility. All animals were pathogen-free and housed in individually ventilated cages (TECNIPLAST S.p.A., Buguggiate, Italy). Animals were maintained under a 12:12-h light-dark cycle at 22°C ± 2°C and 40%–60% relative humidity, with free access to food (CE2, CLEA Japan, Inc., Tokyo, Japan) and water. All animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee of Kanazawa Medical University. All experiments were conducted in accordance with the Animal Experimentation Guidelines of the Kanazawa Medical University.

2.2 Preparation of mouse embryos

Embryos were prepared by in vitro fertilization (IVF) based on our previous reports (Nishizono et al., 2020). HTF medium (ARK Resource Co., Ltd., Kumamoto, Japan) was used for sperm preculture and IVF, and KSOM medium (ARK Resource Co., Ltd.) was used for embryo washing. IVF was performed using fresh or frozen sperm. IVF using frozen sperm was performed as reported previously (Ishizuka et al., 2013) with HTF containing 1 mM reduced l-glutathione (G6013; Sigma-Aldrich Co. LLC, St. Louis, MO, United States) for pre-culturing thawed sperm. For freezing and thawing of sperm, a commercial kit (FERTIUP, Kyudo Co., Ltd., Tosu, Japan) was used according to the manufacturer’s protocol. After removing extra sperm and cumulus cells, embryos were cultured in KSOM at 37°C.

2.3 Generation of Tle6 KO mice using CRISPR-Cas9 system

To generate Tle6 KO mice, crRNAs were designed using CRISPR-direct (https://crispr.dbcls.jp/) (Naito et al., 2015) and Benchling (Benchling, San Francisco, CA, United States, https://www.benchling.com/). Information regarding the primers used for PCR genotyping is provided in Supplementary Table S1. TracrRNA, crRNA, and the Cas9 protein were purchased from Integrated DNA Technologies, Inc. (IA, United States). To generate Tle6 KO mice, we performed embryo genome editing using an electroporator (Nepa Gene Co., Ltd., Chiba, Japan) according to the method described in our previous report (Nishizono et al., 2020). After electroporation, embryos were transferred into recipient mice at the 2-cell stage.

2.4 Genotyping

DNA was extracted from the ear tissue using the HotSHOT method (Schapira et al., 2017). Specifically, ear tissues from ≥ 2-week-old mice were added to 180 µL of 50 mM NaOH (37439-95; Nacalai Tesque, Inc., Kyoto, Japan) and heated at 95°C for 10 min. After alkaline treatment, 20 µL of 1 M Tris HCl (pH 8.0; 06938-44; Nacalai Tesque, Inc.) was added to the sample. Extracted genomic DNA was used as a template for PCR genotyping. PCR was performed using KOD FX NEO (TOYOBO Co., Ltd., Osaka, Japan) according to the manufacturer’s instructions. Information regarding the primers used for PCR genotyping is provided in Supplementary Table S1. After purifying the extracted genomic DNA using NucleoSpin® Gel and PCR Clean-up (Takara Bio Inc., Shiga, Japan), Sanger sequencing was performed using the services of Eurofin Genomics (Eurofins Genomics K.K., Tokyo, Japan). Sequence data were aligned with reference sequences using benchmarking to confirm the deletion of Tle6.

2.5 Histological examination of mouse testes with hematoxylin-eosin (H&E) staining

H&E-stained sections of testicular tissues were prepared using the histology services at Kanazawa Medical University following standard protocols. Briefly, the testes were collected from wild-type and Tle6+/− male mice and fixed overnight in 4% paraformaldehyde-phosphate buffer (PFA: 09154-14; Nacalai Tesque, Inc.). The specimens were dehydrated in graded alcohol solutions and immersed in xylene for dialysis. After immersion in paraffin for 12 h, the specimens were embedded in paraffin blocks, and sections of 3–4 µm thickness were prepared using a rotary microtome. Sections were then deparaffinized with xylene, rehydrated, dexylenized in graded alcohol solutions, and stained with H&E. The prepared H&E-stained slides were observed using a BZ-X700 microscope (Keyence, Osaka, Japan).

2.6 Measurement of testosterone levels

Blood was collected from mice via cardiac puncture and allowed to stand in the dark at room temperature for 15 min. The samples were then centrifuged at 3,000 rpm for 10 min, and the supernatant was collected. Serum testosterone levels were measured using a chemiluminescence immunoassay method, which was outsourced to the Japan Institute for the Control of Aging, Nikken SEIL Co., Ltd. (Shizuoka, Japan). Testosterone levels were measured using pooled serum samples from three wild-type and three Tle6+/− male mice, respectively.

2.7 Sperm count and motility analysis

Sperm were collected from the cauda epididymis of male mice and analyzed for number and motility using the Makler® Counting Chamber (Sefi-Medical Instruments Ltd., Haifa, Israel). The sperm count and motility were measured according to the manufacturer’s instructions.

2.8 Quantitative PCR (qPCR) analysis of spermatozoa in mouse cauda epididymis

For the analysis of Tle6 levels in sperm DNA, sperm were collected from the cauda epididymis of mice into approximately 30 μL of HTF medium. From this sample, sperm were randomly collected from three different locations. DNA was extracted using NucleoSpin DNA Rapid Lysis (Takara Bio, Inc.). Genomic DNA concentration was measured using a NanoDrop Lite Plus (Thermo Fisher Scientific, Inc., Waltham, MA, United States) and adjusted such that the DNA amounts were equal across all groups.

For the measurement of gene expression levels in the testis, the tissue was homogenized using TaKaRa BioMasher Standard (9791A; Takara Bio Inc.). Total RNA was then extracted and reverse-transcribed into cDNA using SYBR™ Green Fast Advanced Cells-to-CT™ Kit (A35379; Thermo Fisher Scientific Inc.). The cDNA was then used for qPCR to compare gene expression levels. The cDNA was obtained from three WT mice and three Tle6+/− mice and was divided into three technical replicates for each group.

The samples were then subjected to qPCR using the THUNDERBIRD™ Next SYBR® qPCR Mix (TOYOBO Co., Ltd.) or SYBR™ Green Fast Advanced Cells-to-CT™ Kit according to the manufacturer’s protocols using the CronoSTAR 96 Real-Time PCR System (Takara Bio Inc.). The primers used for qPCR were designed using Primer3Plus (https://www.primer3plus.com/) and Blast (Supplementary Table S1).

2.9 Immunofluorescence staining

Immunofluorescence staining of sperm was performed with slight modifications following the method described by Yu et al. (2014). Details of the antibodies and DAPI are provided in Supplementary Table S2. In brief, frozen sperm were thawed at 37°C for 10 min and then fixed in 4% PFA with 0.2% Triton-X 100 (35501-02; Nacalai Tesque, Inc.). After blocking with 3% BSA in PBS containing 0.5% Triton X-100 at room temperature (RT) for 1 h, the samples were incubated with mouse anti-TLE6 antibody (1:500, SC-515065; Santa Cruz Biotechnology, TX, United States) at 4°C overnight. The samples were incubated with goat anti-Mouse IgG (1: 500, ab150113; Abcam, Cambridge, United Kingdom) at RT for 1 h. Finally, the samples were treated with DAPI (1 ng/mL, 19178-91; Nacalai Tesque, Inc.), and sperm morphology was observed using a fluorescence microscope (BZ-X 700) with glass-bottom dishes.

2.10 Observation of sperm morphology

After thawing frozen sperm at 37°C for 10 min, sperm were fixed in a tube containing 4% PFA at room temperature for 20 min. The samples were then centrifuged at 3,000 rpm for 5 min, followed by three washes with 0.1% Poly vinyl alcohol (341584; Sigma-Aldrich Co. LLC) dissolved in PBS. After centrifugation, the sperm were stained with DAPI (1 ng/mL) and observed for morphology using a confocal fluorescence microscope (LSM701; Zeiss, Jena, Germany).

2.11 Statistical analysis

To test the genotype distribution of the offspring, a chi-square goodness-of-fit test was performed against the standard genotype distribution. We used the Student’s t-test for other data comparisons. The number of spermatozoa and motile sperm was reported as mean ± standard deviation (SD). The significance level was set at p < 0.05, and two-tailed tests were applied. All the analyses were performed using Python 3 and Microsoft Excel.

3 Results

3.1 Generation of Tle6 KO mouse lines using the CRISPR-Cas9 system

We generated Tle6 KO mice to investigate the effects of Tle6 deficiency in males. We performed genome editing of the embryos using the CRISPR-Cas9 system and electroporation to generate Tle6 KO mice. The gRNA sequences were designed to knock out the entire Tle6 coding sequence (CDS) (Figures 1A, B). Genotypes of mice born from genome-edited embryos were confirmed by genotyping PCR (Figure 1C), and deletion of the CDS in Tle6 KO mice was determined by Sanger sequencing (Figure 1D). We transferred 978 two-cell embryos to pseudopregnant females to obtain 146 live pups. However, only a limited number of Tle6 KO mice were obtained (WT: Tle6+/−: Tle6−/− = 91.1%: 8.1%: 0%). No mosaicism was detected in the sequencing results.

Figure 1
www.frontiersin.org

Figure 1. Generation of Tle6 KO mouse lines using the CRISPR-Cas9 system. (A), Tle6 knockout (KO) design scheme. The upper row shows the wild-type (WT) Tle6. The lower row shows the KO design. The gRNAs were designed to delete the entire coding sequence (CDS) region, resulting in a KO size of 9.4 kb. (B), The experimental scheme used to create Tle6 KO embryos using performing genome editing of in vitro fertilized embryos. Embryos edited by electroporation were transferred to recipient mice at the two-cell stage, and pups were produced. (C), Genotyping PCR of offspring derived from Tle6 KO embryos. LM shows wild-type Tle6. LR shows Tle6 after KO. (D), The sequence of Founder mice with confirmed Tle6 KO. The upper row (LM) shows a wild-type sequence. The lower row (LR) shows Tle6 after KO. (E), In vitro fertilization (IVF) scheme using male and female Tle6+/− KO founder mice. (F), Genotype distribution of the offspring derived from embryos produced by IVF using Tle6+/− male and female mice (n = 3 replicates, 13 animals, 264 embryos). (G), Representative photo of the uterus after cesarean section.

To generate Tle6+/− male mice, we performed IVF and embryo transfer (ET) using Tle6+/− females and males (Figure 1E). We transferred 261 embryos into pseudo-pregnant females and obtained 23 WT, 15 Tle6+/−, and five Tle6−/− mice (Figure 1F). According to Mendelian laws, the crossbreeding of heterozygotes should yield a ratio of one Tle6−/−: two Tle6+/−: one WT. However, the observed ratio was one Tle6−/−: three Tle6+/−: 4.6 WT. The genotype proportions differed significantly from the expected genotype proportions (χ2 = 19.0, p = 7.485 × 10−5). Upon examining whether fertilized eggs were arrested during embryonic development in the uteri of pseudo-pregnant females, we found no embryos with arrested development after implantation (Figure 1G). The substantially lower number of heterozygous embryos than anticipated was unexpected. Given that Tle6−/− mice were not obtained via IVF-ET, we used Tle6+/− male mice for subsequent phenotypic analysis.

3.2 Tle6 KO is rarely transmitted to offspring through natural mating

First, to investigate whether Tle6 deficiency affects mating behavior, we conducted breeding experiments using natural mating. Each Tle6+/− and WT male mice were mated with two C57BL/6N WT female mice for 1 week, and mating was confirmed 20 days later (Figure 2A). Herein, we found that the mating frequency of Tle6+/− male mice did not differ from that of WT mice (each at 62.5%), and the number of offspring was also comparable to that of WT mice (Figure 2B, WT: Tle6+/− = 7.40 ± 1.14: 7.80 ± 1.30, p = 0.6195). These results suggest that Tle6 deficiency does not affect mating behavior or fertility.

Figure 2
www.frontiersin.org

Figure 2. Natural mating using Tle6+/− male mice and wild-type (WT) female mice. (A), Experimental scheme for natural mating using Tle6+/− Founder male mice and WT female mice. Two female mice were mated with one male mouse for 1 week. (B), Number of offspring produced by natural mating using WT female mice and Tle6+/− or WT male mice (n = 4 replicates, 20 animals). (C), Genotype distribution of offspring derived from Tle6+/− Founder male mice and WT female mice (WT n = 22, Tle6+/−: n = 10). (D), Representative photos of embryos produced by in vitro fertilization using sperm from WT and Tle6+/− mice. (E), Embryonic development rates of embryos produced by in vitro fertilization using sperm from WT and Tle6+/− mice (WT mice n = 4, embryos n = 112, Tle6+/− mice: n = 10, embryos n = 85).

The genotypes of F1 mice born through natural mating were confirmed by PCR and Sanger sequencing. Interestingly, most mice were WT, and very few Tle6+/− mice were obtained (Figure 2C). According to Mendelian inheritance, Tle6+/− and WT mice should be born in a 1:1 ratio when Tle6+/− and WT mice are bred. However, the results of this experiment differed significantly (χ2 = 4.5, p = 0.0339). This phenomenon is consistent with the results shown in Figure 1F.

It is known that Tle6-deficient oocytes are embryonic lethality, then we hypothesized that embryos derived from Tle6 KO sperm might exhibit similar reduced developmental rate. To exam this hypothesis, we performed IVF using Tle6+/− male mice sperm and in vitro culture (Figure 2D). However, embryos derived from Tle6+/− male mice sperm showed similar developmental rate compared to that derived from WT male mice sperm (Figure 2E). These results indicated that Tle6+/− mice exhibited specific abnormalities in sperm rather than atypical mating behavior or fertility, hindering the transmission of the Tle6 KO to the next generation.

3.3 Tle6+/− mice are able to produce spermatozoa; however many of them exhibit abnormal morphology and low motility

We hypothesized that the difficulty in transmitting genetic traits from Tle6+/− male mice could be due to reduced sperm count and motility. If the number and motility of Tle6 KO sperm are decreased, sperm carrying Tle6 KO genetic trait would likely be unable to swim to the oviduct ampulla in the female reproductive tract and fertilize the oocytes. Consequently, the likelihood of Tle6 KO genetic trait being passed on to the next generation would be reduced. To test this hypothesis, we analyzed the testes and sperm of Tle6+/− male mice.

First, we compared the testes of WT and Tle6+/− mice and found no morphological abnormalities (Figure 3A). Similarly, no morphological abnormalities were found in the cauda epididymis of Tle6+/− male mice (Figure 3B), and there was no significant difference in the size of the cauda epididymis between the two groups (WT: Tle6+/− = 2.98 ± 0.21 mm: 3.08 ± 0.10 mm, p = 0.426, Student’s t-test).

Figure 3
www.frontiersin.org

Figure 3. Analysis of sperm production in the male reproductive tissues of WT and Tle6+/− mice (A), Testis of WT C57BL/6N mice (left) and Tle6+/− mice (right) (B), Cauda epididymis of WT C57BL/6N mice (left) and Tle6+/− mice (right). (C), qPCR of sperm from WT C57BL/6N mice and Tle6+/− mice (n = 3 replicates). (D), Hematoxylin and eosin staining of testes of WT C57BL/6N mice (left) and Tle6+/− mice (right). Arrowhead indicates spermatids near the center of the seminiferous tubules.

Next, we examined whether Tle6 KO spermatozoa was suppressed in the testes of Tle6+/− male mice. Consequently, we performed qPCR using spermatozoa derived from WT and Tle6+/− male mice. For qPCR, spermatozoa were collected from three regions of the cauda epididymis from both WT and Tle6+/− mice. The analysis was conducted using a consistent amount of DNA extracted from sperm genomes. Since the primers for qPCR were designed at the Tle6 knockout site, it was anticipated that the quantity of the Tle6 gene in Tle6+/− mice would be half of that in WT mice. However, the Tle6 gene quantity in spermatozoa derived from Tle6+/− mice was less than 30% of that in spermatozoa from WT mice (Figure 3C), with a relative level of 0.289 compared to sperm from WT mice (χ2 = 1.6637, p = 0.1971 × 10−2). No significant differences were observed between groups. These results indicate that Tle6-deficient sperm were present in the cauda epididymis of Tle6 KO mice, and although there was no significant difference in the ratio, their number was higher than that of normal sperm, with an estimated 70% of sperm being deficient in Tle6. The reduced number of motile sperm in the semen of Tle6+/− mice could be attributed to the high proportion of Tle6-deficient sperm.

Finally, to investigate sperm abnormalities more thoroughly, we compared spermatogonia, testis structure, sperm count, motility, and sperm morphology. HE-stained sections of the testes were prepared using the testes of WT and Tle6+/− male mice. While no obvious differences in testis structure were observed, the interstitial tissue of Tle6+/− mice appeared a little shrunken. Suspecting that this shrinkage might be due to abnormalities in hormone levels, we analyzed serum testosterone levels in both WT and Tle6+/− male mice. The results showed that testosterone level in Tle6+/− mice were significantly higher than that in WT mice (WT: 651 ng/L, Tle6+/−: 7,804 ng/L). Then, spermatids were occasionally detected near the center of the seminiferous tubules in Tle6+/− mice, and enucleated cytoplasmic remnants were also observed. These findings suggest that meiotic failure may occur in spermatids of Tle6+/− male mice (Figure 3D). The sperm count in Tle6+/− mice was significantly lower than in WT mice (Table 1, p = 0.012). Additionally, analysis of sperm motility in Tle6+/− mice showed a significantly reduced in number of motile sperm (Table 2).

Table 1
www.frontiersin.org

Table 1. Sperm number of wild-type C57BL/6N mice and Tle6+/− mice.

Table 2
www.frontiersin.org

Table 2. Sperm motility of wild-type C57BL/6N mice and Tle6+/− mice.

To assess Tle6 protein levels in sperm, we performed immunofluorescence staining on sperm from WT and Tle6+/− mice. TLE6 levels in Tle6+/− male mice were found to be less than half of those in WT mice (p = 5.013 × 10−14). Furthermore, Tle6 was localized in the sperm midpiece. This localization partially overlapped with the mitochondrial sheath, suggesting that TLE6 might be involved in energy production in sperm (Figure 4A). Furthermore, we observed sperm morphology and found that while normal sperm were present, 57% sperm exhibited abnormal head shapes (crumpled appearance and displaced nuclei) and 7% double-headed sperm in Tle6+/− mice. These results suggest that Tle6 deficiency leads to the production of abnormal sperm and reduces sperm count and motility.

Figure 4
www.frontiersin.org

Figure 4. Analysis of testes and spermatozoa of Tle6 KO heterozygous male mice (A), Immunofluorescence staining of sperm from the cauda epididymis of WT and Tle6+/− mice: the left panel shows sperm from WT mice, and the right panel shows sperm from Tle6+/− mice. Blue indicates DAPI staining, and green indicates TLE6 staining. The lower graph shows the relative protein level of TLE6 in sperm, normalized to the average TLE6 protein level in sperm from WT mice (WT: sperm derived from wild-type male mice n = 41, Tle6+/−: sperm derived from Tle6+/− male mice n = 32). (B), Spermatozoa in cauda epididymis of WT mice (WT), normal sperm (normal), abnormal acrosome sperm (abnormal-1), and deformed sperm (abnormal-2) of Tle6+/− mice (three right panels). (C), Quantification of the expression levels of fertilization-related genes in mouse testes analyzed by real-time PCR. The results for each gene were normalized to the average value from WT mice, with expression levels in both WT and Tle6+/− mice adjusted accordingly. The X-axis represents the genotype of the mice, and the Y-axis shows the relative expression levels compared to WT (n = 3 animals).

The abnormalities in sperm from Tle6+/− mice suggest that genes related to fertilization may be affected. To investigate the downstream genes impacted by Tle6 deletion, we assessed the expression levels of three key genes: Adam3, Ppp3cc, and Catsper, which are known to play roles in sperm motility, fertilization, and sperm morphology. The expression levels of these genes in testicular cells generally tended to be higher in Tle6+/− mice, with Catsper showing a significant increase (Adam3: p = 0.1806, Ppp3cc: p = 0.097, Catsper: p = 0.046).

4 Discussion

In this study, we generated novel Tle6 KO mice to investigate the effects of TLE6 mutations and deletions on the male germline. The genotype distribution of the offspring did not follow Mendelian laws, indicating that the deletion of Tle6 was unlikely to be transmitted to the next-generation (Figure 2C). Upon analyzing the genotype of sperm in the cauda epididymis of Tle6+/− mice, we detected higher numbers of Tle6-deficient sperm than WT sperm (Figure 3C). While deletion of Tle6 did not have a major impact on the morphology of the testes or cauda epididymis (Figures 3A, B), a slight contraction of the testicular interstitium was observed (Figure 3D), along with a significant increase in testosterone levels. Tle6+/− mice had a lower sperm count than WT mice (Table 1). Notably, the number of motile sperm was reduced (Table 2). Moreover, many spermatozoa had abnormal morphology (Figure 4B). Additionally, gene expression related to fertilization, sperm motility, and sperm morphology in the testes of Tle6+/− mice showed an overall upward trend, with Catsper in particular showing a significant increase in expression (Figure 4C). The decrease in the number of healthy functional sperm, despite the high number of Tle6-deficient sperm in the cauda epididymis, suggests that Tle6-deficient sperm can process incorrect spermatogenesis and induce sperm dysfunction.

TLE6 is a component of the SCMC and plays an important role in the early embryonic development of oocytes and embryos (Jentoft et al., 2023). However, the function of TLE6 in male germ cells remains poorly clarified; therefore, we analyzed the role of TLE6 using newly generated Tle6 KO mice. Our results indicate that, unlike previous reports (Yu et al., 2014), the genetic traits of Tle6+/− mice are rarely transmitted to the next generation (Figures 1F, 2C). This discrepancy is likely due to larger deletions in the genomic regions of our Tle6 KO mice when compared with those performed in previous studies (Yu et al., 2014). In the current study, the generated Tle6 KO mice had exons 2–14 deleted, whereas the mice used by Yu et al. had exons 1–2 replaced with a neomycin-resistant cassette. Tle6 encodes the tryptophan-aspartic acid 40 repeat (WDR) domain in the CDS from exon 2 onward, and specific regions within this domain mediate interactions with other proteins forming the SCMC (Chi et al., 2024). Interestingly, the WDR domain is crucial for protein-protein interactions and is involved in several physiological activities, including the cell cycle (Schapira et al., 2017). It has also gained attention as a potential target for drug discovery. Therefore, this region likely contains elements critical for sperm function. It is highly likely that this crucial domain was not reliably deleted in previously reported mice. In future studies, we plan to analyze the protein function of the missing region in KO mice using a structural biology approach.

We also found that Tle6 deficiency led to the production of abnormal sperm (Figure 4B) and a decrease in both the number and motility of sperm in the cauda epididymis (Tables 1, 2). However, the efficiency of natural mating in Tle6+/− mice was not reduced when compared with that in WT mice (Figure 2B). Considering these results, along with the comparison of sperm genotypes in the cauda epididymis shown in Figure 3C, it seems likely that even in the presence of substantial Tle6-deficient sperm with reduced motility and other phenotypes, the remaining motile WT sperm will fertilize the egg. Therefore, we speculate that the male genetic trait of Tle6 deficiency is unlikely to be transmitted to the next generation. Feng et al. reported that the loss of Tle6 in spermatogonia causes abnormalities in the cell cycle and proliferation rate of sperm cells. Our results showed a reduction in sperm count, which closely aligns with their findings. We also observed the presence of cells like spermatids in the center of the seminiferous tubules of Tle6+/− mice (Figure 3D). This observation suggests a failure in meiosis during spermatogenesis. To the best of our knowledge, this is the first report documenting a decrease in sperm in Tle6 KO mice. Additionally, the abnormally high levels of testosterone may indicate dysfunction in the testes of Tle6+/− mice. While it is generally known that an increase in testosterone typically leads to a higher sperm count, no positive correlation was observed between changes in testosterone levels and sperm count in this study. Further research is needed to clarify this phenomenon.

Furthermore, we found that Tle6 deficiency leads to the production of abnormal sperm (Figure 4B). These findings suggested that Tle6 deficiency affects correct spermatogenesis. Although, we observed an upward trend in the expression of genes related to sperm motility and morphology in the testes of Tle6+/− mice, Catsper was the only gene that showed a significant increase (Figure 4C). These increase in gene expression is likely due to the knockout of Tle6, as TLE6 is known to function as a DNA corepressor.

It is important to note that this study focused on a specific region of Tle6-deficient mice (exon 2-14 knock out). While we observed a reduction in sperm count and motility, these symptoms have not been reported in other studies using different Tle6 KO model mice. Moreover, the role of TLE6 in spermatogenesis may vary between humans and mice. Therefore, further research is necessary to clarify the mechanisms by which Tle6 deficiency causes sperm abnormalities in Tle6 KO mice and to explore its clinical relevance in humans.

In this study, we generated Tle6 KO mice to determine the effects of TLE6 mutations on the male germline. Tle6+/− mice did not follow Mendelian inheritance and showed no morphological changes in the testes or spermatogonia. However, the production of sperm with abnormal morphology, as well as sperm count and motility, were significantly reduced, suggesting that Tle6 deficiency results in incorrect spermatogenesis. While the effects of Tle6 deficiency on males have rarely been reported, they may be related to potential male infertility. Nonetheless, these results are based on studies in mice and may not fully apply to humans.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Ethics statement

The animal study was approved by The Institutional Animal Care and Use Committee of Kanazawa Medical University. The study was conducted in accordance with the local legislation and institutional requirements.

Author contributions

KK: Conceptualization, Data curation, Investigation, Methodology, Software, Visualization, Writing–original draft, Writing–review and editing. YM: Investigation, Writing–review and editing. HN: Conceptualization, Funding acquisition, Project administration, Supervision, Writing–original draft, Writing–review and editing.

Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Takeda Science Foundation (Grant No. 2022048848), Lotte Research Promotion Grant (Grant No. LF001353) and a Grant for Promoted Research from Kanazawa Medical University (S2023-1).

Acknowledgments

We thank the members of the Office for Animal Resources at Kanazawa Medical University for their assistance with animal breeding. We also thank Yuka Hiramatsu for her help in preparing the H&E stained slides. Additionally, we would like to extend our sincere thanks to Prof. Shinichi Nakagawa and Prof. Toshihisa Hatta for their valuable advice and guidance throughout the course of this research, as well as to Prof. Teruhiko Wakayama for checking the manuscript.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcell.2024.1481659/full#supplementary-material

References

Akbari, M., Mohebi, M., Berjis, K., Ghahremani, A., Modarressi, M. H., and Ghafouri-Fard, S. (2022). A novel variant in TLE6 is associated with embryonic developmental arrest (EDA) in familial female infertility. Sci. Rep. 12, 17664. doi:10.1038/s41598-022-22687-y

PubMed Abstract | CrossRef Full Text | Google Scholar

Alazami, A. M., Awad, S. M., Coskun, S., Al-Hassan, S., Hijazi, H., Abdulwahab, F. M., et al. (2015). TLE6 mutation causes the earliest known human embryonic lethality. Genome Biol. 16, 240. doi:10.1186/s13059-015-0792-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Bebbere, D., Albertini, D. F., Coticchio, G., Borini, A., and Ledda, S. (2021). The subcortical maternal complex: emerging roles and novel perspectives. Mol. Hum. Reprod. 27, gaab043. doi:10.1093/molehr/gaab043

PubMed Abstract | CrossRef Full Text | Google Scholar

Bebbere, D., Ariu, F., Bogliolo, L., Masala, L., Murrone, O., Fattorini, M., et al. (2014). Expression of maternally derived KHDC3, NLRP5, OOEP and TLE6 is associated with oocyte developmental competence in the ovine species. BMC Dev. Biol. 14, 40. doi:10.1186/s12861-014-0040-y

PubMed Abstract | CrossRef Full Text | Google Scholar

Chi, P., Ou, G., Qin, D., Han, Z., Li, J., Xiao, Q., et al. (2024). Structural basis of the subcortical maternal complex and its implications in reproductive disorders. Nat. Struct. Mol. Biol. 31, 115–124. doi:10.1038/s41594-023-01153-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Feng, M., Bai, Y., Chen, Y., and Wang, K. (2020). Knockout of the transducin-like enhancer of split 6 gene affects the proliferation and cell cycle process of mouse spermatogonia. Int. J. Mol. Sci. 21, 5827. doi:10.3390/ijms21165827

PubMed Abstract | CrossRef Full Text | Google Scholar

Giaccari, C., Cecere, F., Argenziano, L., Pagano, A., Galvao, A., Acampora, D., et al. (2024). A maternal-effect Padi6 variant causes nuclear and cytoplasmic abnormalities in oocytes, as well as failure of epigenetic reprogramming and zygotic genome activation in embryos. Genes Dev. 38, 131–150. doi:10.1101/gad.351238.123

PubMed Abstract | CrossRef Full Text | Google Scholar

Ishizuka, Y., Nishimura, M., Matsumoto, K., Miyashita, M., Takeo, T., Nakagata, N., et al. (2013). The influence of reduced glutathione in fertilization medium on the fertility of in vitro-matured C57BL/6 mouse oocytes. Theriogenology 80, 421–426. doi:10.1016/j.theriogenology.2013.07.002

PubMed Abstract | CrossRef Full Text | Google Scholar

Jentoft, I. M. A., Bäuerlein, F. J. B., Welp, L. M., Cooper, B. H., Petrovic, A., So, C., et al. (2023). Mammalian oocytes store proteins for the early embryo on cytoplasmic lattices. Cell 186, 5308–5327.e25. doi:10.1016/j.cell.2023.10.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Jiao, S.-Y., Yang, Y.-H., and Chen, S.-R. (2021). Molecular genetics of infertility: loss-of-function mutations in humans and corresponding knockout/mutated mice. Hum. Reprod. Update 27, 154–189. doi:10.1093/humupd/dmaa034

PubMed Abstract | CrossRef Full Text | Google Scholar

Lin, J., Xu, H., Chen, B., Wang, W., Wang, L., Sun, X., et al. (2020). Expanding the genetic and phenotypic spectrum of female infertility caused by TLE6 mutations. J. Assist. Reprod. Genet. 37, 437–442. doi:10.1007/s10815-019-01653-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Naito, Y., Hino, K., Bono, H., and Ui-Tei, K. (2015). CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites. Bioinformatics 31, 1120–1123. doi:10.1093/bioinformatics/btu743

PubMed Abstract | CrossRef Full Text | Google Scholar

Nishizono, H., Darwish, M., Endo, T. A., Uno, K., Abe, H., and Yasuda, R. (2020). Glycine receptor α4 subunit facilitates the early embryonic development in mice. Reproduction 159, 41. doi:10.1530/REP-19-0312

PubMed Abstract | CrossRef Full Text | Google Scholar

Schapira, M., Tyers, M., Torrent, M., and Arrowsmith, C. H. (2017). WD40 repeat domain proteins: a novel target class?. Nat. Rev. Drug Discov. 16, 773–786. doi:10.1038/nrd.2017.179

PubMed Abstract | CrossRef Full Text | Google Scholar

Vander Borght, M., and Wyns, C. (2018). Fertility and infertility: definition and epidemiology. Clin. Biochem. 62, 2–10. doi:10.1016/j.clinbiochem.2018.03.012

PubMed Abstract | CrossRef Full Text | Google Scholar

WHO (2023). Infertility prevalence estimates, 1990–2021.

Google Scholar

Yu, X.-J., Yi, Z., Gao, Z., Qin, D., Zhai, Y., Chen, X., et al. (2014). The subcortical maternal complex controls symmetric division of mouse zygotes by regulating F-actin dynamics. Nat. Commun. 5, 4887. doi:10.1038/ncomms5887

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: transducin-like enhancer of split 6, subcortical maternal complex, infertility, male germ cell, sperm

Citation: Kazama K, Miyagoshi Y and Nishizono H (2024) Tle6 deficiency in male mice led to abnormal sperm morphology and reduced sperm motility. Front. Cell Dev. Biol. 12:1481659. doi: 10.3389/fcell.2024.1481659

Received: 16 August 2024; Accepted: 15 October 2024;
Published: 24 October 2024.

Edited by:

Anna Ptak, Jagiellonian University, Poland

Reviewed by:

Dan Cheng, National Institutes of Health (NIH), United States
Malgorzata Aneta Kotula-Balak, University of Agriculture in Krakow, Poland

Copyright © 2024 Kazama, Miyagoshi and Nishizono. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hirofumi Nishizono, aGlyb2Z1bWlAa2FuYXphd2EtbWVkLmFjLmpw

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.